ALUR Allurion Technologies Inc.
Healthcare$0.80-3.54%ClosedMarket Cap: $6.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.42
P/S
0.50
EV/EBITDA
-0.79
DCF Value
$-33.36
FCF Yield
-363.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.7%
Operating Margin
-211.2%
Net Margin
-264.7%
ROE
44.2%
ROA
-238.3%
ROIC
-503.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.9M | 41.7% | $-3.7M | $-6.1M | $— | — |
| Q4 null | $3.6M | 44.5% | $-6.3M | $-6.0M | $— | — |
| FY null | $15.2M | 62.8% | $-30.2M | $-28.8M | $— | — |
| Q3 null | $2.7M | 49.1% | $-9.6M | $-11.9M | $— | — |
| Q2 null | $3.4M | 73.9% | $-7.0M | $-9.3M | $— | — |
| Q1 null | $5.6M | 74.6% | $-7.3M | $-1.5M | $— | — |
| Q4 null | $5.6M | 45.3% | $-17.1M | $-20.6M | $— | — |
| FY null | $32.1M | 67.0% | $-50.2M | $-26.1M | $— | — |
| Q3 null | $5.4M | 58.0% | $-12.3M | $-9.0M | $— | — |
| Q2 null | $11.8M | 76.4% | $-9.3M | $-8.3M | $— | — |
| Q1 null | $9.4M | 73.2% | $-11.4M | $5.6M | $— | — |
| Q4 2023 | $8.2M | 78.1% | $-25.7M | $-19.2M | $-10.09 | — |